Houston, TX
United States
University of Texas at Houston - Department of Lymphoma and Myeloma
Follicular Lymphoma, B-Cell Lymphoma, Lenalidomide, Therapeutic Use, Obinutuzumab, Antineoplastic Agents, Immunological
single-cell RNA sequencing (scRNAseq), multiple myeloma (MM), monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), single-cell B cell receptor sequencing (scBCR-seq), plasma cells (PCs), intra-tumoral heterogeneity (ITH), tumor microenvironment (TME), hyperdiploid (HY), non-hyperdiploid (non-HY)
CAR T-cell, B-cell lymphoma, Cytopenia, Interferon